02/04/2024
Stefano Gentileschi Carla Gaggiano Arianna Damiani Carmela Coccia Pamela Bernardini Massimiliano Maxic Francesco D'Alessandro Giulia Vallifuoco Riccardo Terribili Marco Bardelli Caterina Baldi Luca Cantarini Marta Mosca Bruno Frediani Serena Guiducci. Impact of age and cardiovascular risk factors on the incidence of adverse events in patients with rheumatoid arthritis treated with Janus Kinase inhibitors: data from a real-life multicentric cohort.
Un sincero ringraziamento a quanti hanno contribuito per la realizzazione di questo lavoro.
Inhibiting Janus Kinases (JAK) is a crucial therapeutic strategy in rheumatoid arthritis (RA). However, the use of JAK inhibitors has recently raised serious safety concerns. The study aims to evaluate the safety profile of JAKi in patients with RA and identify potential risk factors (RFs) for adver...